Page last updated: 2024-08-21

ethyl pyruvate and B16 Melanoma

ethyl pyruvate has been researched along with B16 Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sakamoto, K; Zhou, S1
Curtis, P; DuHadaway, JB; Jaller, D; Metz, R; Muller, AJ; Prendergast, GC1

Other Studies

2 other study(ies) available for ethyl pyruvate and B16 Melanoma

ArticleYear
Pyruvic acid/ethyl pyruvate inhibits melanogenesis in B16F10 melanoma cells through PI3K/AKT, GSK3β, and ROS-ERK signaling pathways.
    Genes to cells : devoted to molecular & cellular mechanisms, 2019, Volume: 24, Issue:1

    Topics: Animals; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; MAP Kinase Signaling System; Melanins; Melanoma, Experimental; Mice; Microphthalmia-Associated Transcription Factor; Models, Biological; Monophenol Monooxygenase; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Pyruvates; Pyruvic Acid; Reactive Oxygen Species

2019
Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate.
    Cancer research, 2010, Mar-01, Volume: 70, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; Cell Growth Processes; Enzyme Inhibitors; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Pyruvates; RNA, Messenger; T-Lymphocytes; U937 Cells

2010